Golinski M - Search Results

1

Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.

Liu S, Huang H, Lu X, Golinski M, Comesse S, Watt D, Grossman RB, Moscow JA. Liu S, et al. Among authors: golinski m. Mol Cancer Res. 2003 Jul;1(9):665-73. Mol Cancer Res. 2003. PMID: 12861052

2

Synthesis and use of a biotinylated 3-azidophenothiazine to photolabel both amino- and carboxyl-terminal sites in calmodulin.

DeLaLuz PJ, Golinski M, Watt DS, Vanaman TC. DeLaLuz PJ, et al. Among authors: golinski m. Bioconjug Chem. 1995 Sep-Oct;6(5):558-66. doi: 10.1021/bc00035a009. Bioconjug Chem. 1995. PMID: 8974454

3

Prostaglandin photoaffinity probes: synthesis and binding affinity of C-18 substituted PGF2 alpha prostanoids bearing a perfluorinated aryl azide.

Golinski M, Heine M, Orlicky DJ, Fitz TA, Watt DS. Golinski M, et al. Eicosanoids. 1992;5(2):87-97. Eicosanoids. 1992. PMID: 1449821

4

Prostaglandin photoaffinity probes: synthesis and binding affinity of aryl azide-substituted C-1 esters of prostaglandin F2 alpha.

Golinski M, Heine M, Orlicky DJ, Fitz TA, Watt DS. Golinski M, et al. Eicosanoids. 1992;5(2):99-107. Eicosanoids. 1992. PMID: 1449822

5

Synthesis and binding affinity of bidentate phenothiazines with two different photoactive groups.

Golinski M, DeLaLuz PJ, Delcamp TJ, Watt DS, Vanaman TC. Golinski M, et al. Bioconjug Chem. 1995 Sep-Oct;6(5):567-72. doi: 10.1021/bc00035a010. Bioconjug Chem. 1995. PMID: 8974455

6

Planarity of nitro-substituted phenothiazines.

Brock CP, DeLaLuz PJ, Golinski M, Lloyd MA, Vanaman TC, Watt DS. Brock CP, et al. Among authors: golinski m. Acta Crystallogr B. 1996 Aug 1;52 ( Pt 4):713-9. doi: 10.1107/s0108768196000201. Acta Crystallogr B. 1996. PMID: 8810494

7

Synthesis, binding affinity, and cross-linking of monodentate photoactive phenothiazines to calmodulin.

Golinski M, DeLaLuz PJ, Floresca R, Delcamp TJ, Vanaman TC, Watt DS. Golinski M, et al. Bioconjug Chem. 1995 Sep-Oct;6(5):549-57. doi: 10.1021/bc00035a008. Bioconjug Chem. 1995. PMID: 8974453

8

Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem.

Kunzler AM, Iannizzi C, Burns J, Metzendorf MI, Voigt-Radloff S, Piechotta V, Schmaderer C, Holzmann-Littig C, Balzer F, Benstoem C, Binder H, Boeker M, Dirnagl U, Fichtner F, Golinski M, Grundmann H, Hengel H, Jabs J, Kern WV, Kopp I, Kranke P, Kreuzberger N, Laudi S, Lichtner G, Lieb K, Maun A, Moerer O, Müller A, Mutters NT, Nothacker M, Pfadenhauer LM, Popp M, Rüschemeyer G, Schmucker C, Schwingshackl L, Spies C, Steckelberg A, Stegemann M, Strech D, von Dincklage F, Weibel S, Wunderlich MM, Zöller D, Rehfuess E, Skoetz N, Meerpohl JJ; CEOsys Consortium. Kunzler AM, et al. Among authors: golinski m. J Clin Epidemiol. 2024 Sep;173:111456. doi: 10.1016/j.jclinepi.2024.111456. Epub 2024 Jul 14. J Clin Epidemiol. 2024. PMID: 39002765 Free article.

9

The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.

Hébert V, Novarino J, Maho-Vaillant M, Perals C, Calbo S, Golinski ML, Martinez F, Joly P, Fazilleau N. Hébert V, et al. Among authors: golinski ml. Br J Dermatol. 2024 Sep 18;191(4):605-615. doi: 10.1093/bjd/ljae220. Br J Dermatol. 2024. PMID: 38848544

10

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: golinski ml. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters